DE3650319T2 - Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv). - Google Patents

Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).

Info

Publication number
DE3650319T2
DE3650319T2 DE3650319T DE3650319T DE3650319T2 DE 3650319 T2 DE3650319 T2 DE 3650319T2 DE 3650319 T DE3650319 T DE 3650319T DE 3650319 T DE3650319 T DE 3650319T DE 3650319 T2 DE3650319 T2 DE 3650319T2
Authority
DE
Germany
Prior art keywords
bursavirus
ibdv
immunogens
infectious
cloning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3650319T
Other languages
English (en)
Other versions
DE3650319D1 (de
Inventor
Ahmed Azad
Peter Hudson
Kevin Fahey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of DE3650319D1 publication Critical patent/DE3650319D1/de
Publication of DE3650319T2 publication Critical patent/DE3650319T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE3650319T 1985-05-30 1986-05-30 Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv). Expired - Lifetime DE3650319T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH081585 1985-05-30
AUPH211885 1985-08-23
PCT/AU1986/000156 WO1986007060A1 (en) 1985-05-30 1986-05-30 Cloning and expression of host-protective immunogens of ibdv

Publications (2)

Publication Number Publication Date
DE3650319D1 DE3650319D1 (de) 1995-06-14
DE3650319T2 true DE3650319T2 (de) 1996-01-25

Family

ID=25642952

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2003199004 Active DE10399004I2 (de) 1985-05-30 1986-05-30 Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv).
DE3650319T Expired - Lifetime DE3650319T2 (de) 1985-05-30 1986-05-30 Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2003199004 Active DE10399004I2 (de) 1985-05-30 1986-05-30 Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv).

Country Status (7)

Country Link
US (2) US6054126A (de)
EP (1) EP0222842B1 (de)
JP (1) JP2988622B2 (de)
CA (1) CA1334941C (de)
DE (2) DE10399004I2 (de)
NL (1) NL300114I2 (de)
WO (1) WO1986007060A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254463A (en) * 1981-09-18 1993-10-19 Genentech, Inc. Method for expression of bovine growth hormone
US5489529A (en) * 1984-07-19 1996-02-06 De Boer; Herman A. DNA for expression of bovine growth hormone
EP0366684B1 (de) * 1987-06-26 1994-01-26 Commonwealth Scientific And Industrial Research Organisation Durch virusneutralisierende und schützende monokonale antikörper erkanntes ibdv vp2 epitop
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
EP0481072A4 (en) * 1990-05-04 1993-06-09 University Of Maryland At College Park Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
WO2000012677A2 (en) * 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
EP1296710A4 (de) * 2000-06-19 2004-05-12 Rahan Meristem Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02)
FR2824327B1 (fr) * 2001-05-02 2003-07-11 Agronomique Inst Nat Rech Particules pseudovirales de birnavirus
US6764684B2 (en) * 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
ES2417019T3 (es) 2003-11-13 2013-08-05 University Of Georgia Research Foundation, Inc. Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
CA1252042A (en) * 1983-12-13 1989-04-04 Kevin J. Fahey Infectious bursal disease virus vaccine
EP0366684B1 (de) * 1987-06-26 1994-01-26 Commonwealth Scientific And Industrial Research Organisation Durch virusneutralisierende und schützende monokonale antikörper erkanntes ibdv vp2 epitop
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
NL300114I1 (nl) 2003-04-01
US6054126A (en) 2000-04-25
DE10399004I2 (de) 2005-09-08
EP0222842A1 (de) 1987-05-27
CA1334941C (en) 1995-03-28
DE3650319D1 (de) 1995-06-14
JPH09316094A (ja) 1997-12-09
EP0222842A4 (de) 1988-10-05
NL300114I2 (nl) 2003-10-01
EP0222842B1 (de) 1995-05-10
JP2988622B2 (ja) 1999-12-13
US5849575A (en) 1998-12-15
DE10399004I1 (de) 2003-06-05
WO1986007060A1 (en) 1986-12-04

Similar Documents

Publication Publication Date Title
DE3689427T2 (de) Klonierung von Restriktions- und Modifikationsgenen.
DE68910713D1 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
DE3767755D1 (de) Mikrobiologische entschwefelung von gasen.
NO874357D0 (no) Rensing av pichia-produserte lipofile proteiner.
DE3650289T2 (de) Spike-protein des virus der infektiösen bronchitis.
DE3650319T2 (de) Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE3777861D1 (de) Behandlung von gasen.
NO873325L (no) Sekresjon av heterologe proteiner av gjaer.
DE3751576T2 (de) Virale Inaktivierung und Reinigung von aktiven Proteinen.
DE3786928T2 (de) Verpackung von schleifmitteln.
FI863517A (fi) Stabilisering.
DE3680000D1 (de) Stabilisierte aktive formen von vitamin-d3.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE3673362D1 (de) Oxydation von flugasche.
DE3486040T2 (de) Klonierung und verwendung von aminotransferase-genen.
FI872960A (fi) Expression av en gen av aids-virus.
DK93886D0 (da) Molekylaer kloning af delta-endotoksingenet af bacillus thuringiensisvar. isroelensis
DE3685258D1 (de) Verwendung von pflanzenprotoplasten.
DE3583858D1 (de) Derivate von alcoxymethylaether und alcoxymethylester.
DE3780849D1 (de) Rueckgewinnung und uebertragung von aroma.
DE3761048D1 (de) Umsetzungsprodukte von bis-glycidylthioethern.
DE3669550D1 (de) Stabilisierung von pechfasern.
DE3869828D1 (de) Stabilisierung von aminalane.
DE3681026D1 (de) Oxidierungsverfahren von 2,6-diisopropylnaphthalin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: PATENTANWAELTE REICHEL UND REICHEL, 60322 FRANKFURT

V448 Application of spc

Free format text: PRODUCT NAME: GALLIVAC HVT IBD REKOMBINANTES VHVT013-69 LEBENDVIRUS; REGISTRATION NO/DATE: EU/2/02/032/001, 20020809

Spc suppl protection certif: 103 99 004

Filing date: 20030124

V457 Spc granted

Free format text: PRODUCT NAME: GALLIVAC HVT IBD REKOMBINANTES VHVT013-69 LEBENDVIRUS; REGISTRATION NO/DATE: EU/2/02/032/001, 20020809

Spc suppl protection certif: 103 99 004

Filing date: 20030124

R071 Expiry of right

Free format text: PRODUCT NAME: GALLIVAC HVT IBD REKOMBINANTES VHVT013-69 LEBENDVIRUS; REGISTRATION NO/DATE: EU/2/02/032/001 20020809

Spc suppl protection certif: 10399004

Filing date: 20030124

Expiry date: 20060531

Extension date: 20110530

Effective date: 20110531